Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Leukemia Research|October 5, 2018
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDSHeather A Leitch, Rena Buckstein, Nancy Zhu, et al.
British Journal of Haematology|October 20, 2004
Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantationCynthia L Toze, Michael J Barnett, Joseph M Connors, et al.
Bone Marrow Transplantation|March 29, 2000
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemiaC L Toze, J D Shepherd, J M Connors, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase InhibitorsAnish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myelomaJohn Kuruvilla, John D Shepherd, Heather J Sutherland, et al.
Bone Marrow Transplantation|August 28, 1998
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantationD R Simpson, T J Nevill, J D Shepherd, et al.
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimensY R Abou-Mourad, B C Lau, M J Barnett, et al.
Bone Marrow Transplantation|October 17, 2003
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisD L Forrest, T J Nevill, S C Naiman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamideAsha Johny, Kevin W Song, Stephen H Nantel, et al.
Pageof 8